nodes	percent_of_prediction	percent_of_DWPC	metapath
Cisapride—HTR2A—narcolepsy	0.763	1	CbGaD
Cisapride—HTR3A—enteric nervous system—narcolepsy	0.0324	0.313	CbGeAlD
Cisapride—HTR2A—enteric nervous system—narcolepsy	0.0131	0.126	CbGeAlD
Cisapride—HTR2A—locus ceruleus—narcolepsy	0.00864	0.0834	CbGeAlD
Cisapride—HTR2A—pons—narcolepsy	0.00498	0.0481	CbGeAlD
Cisapride—HTR2A—autonomic nervous system—narcolepsy	0.00459	0.0443	CbGeAlD
Cisapride—HTR4—brain—narcolepsy	0.00407	0.0394	CbGeAlD
Cisapride—HTR3A—brainstem—narcolepsy	0.00275	0.0265	CbGeAlD
Cisapride—HTR3A—forebrain—narcolepsy	0.00265	0.0256	CbGeAlD
Cisapride—HTR2C—brainstem—narcolepsy	0.00221	0.0213	CbGeAlD
Cisapride—HTR2C—forebrain—narcolepsy	0.00213	0.0206	CbGeAlD
Cisapride—HTR2B—forebrain—narcolepsy	0.002	0.0193	CbGeAlD
Cisapride—DRD2—brainstem—narcolepsy	0.00168	0.0162	CbGeAlD
Cisapride—DRD2—forebrain—narcolepsy	0.00162	0.0157	CbGeAlD
Cisapride—KCNH2—forebrain—narcolepsy	0.0016	0.0154	CbGeAlD
Cisapride—HTR2C—medulla oblongata—narcolepsy	0.00154	0.0149	CbGeAlD
Cisapride—Iloperidone—HTR2A—narcolepsy	0.00152	1	CrCbGaD
Cisapride—HTR2C—midbrain—narcolepsy	0.00141	0.0136	CbGeAlD
Cisapride—KCNH2—medulla oblongata—narcolepsy	0.00115	0.0112	CbGeAlD
Cisapride—HTR2A—brainstem—narcolepsy	0.00111	0.0107	CbGeAlD
Cisapride—HTR3A—brain—narcolepsy	0.0011	0.0106	CbGeAlD
Cisapride—CYP2A6—brain—narcolepsy	0.00108	0.0104	CbGeAlD
Cisapride—DRD2—midbrain—narcolepsy	0.00107	0.0103	CbGeAlD
Cisapride—HTR2A—forebrain—narcolepsy	0.00107	0.0103	CbGeAlD
Cisapride—KCNH2—midbrain—narcolepsy	0.00106	0.0102	CbGeAlD
Cisapride—CYP2D6—brainstem—narcolepsy	0.00101	0.00975	CbGeAlD
Cisapride—CYP2D6—forebrain—narcolepsy	0.000974	0.00941	CbGeAlD
Cisapride—HTR2C—brain—narcolepsy	0.000885	0.00855	CbGeAlD
Cisapride—HTR2B—brain—narcolepsy	0.000831	0.00803	CbGeAlD
Cisapride—HTR2A—medulla oblongata—narcolepsy	0.000773	0.00746	CbGeAlD
Cisapride—HTR2A—midbrain—narcolepsy	0.000706	0.00682	CbGeAlD
Cisapride—DRD2—brain—narcolepsy	0.000673	0.0065	CbGeAlD
Cisapride—KCNH2—brain—narcolepsy	0.000663	0.0064	CbGeAlD
Cisapride—CYP2C8—brain—narcolepsy	0.000607	0.00586	CbGeAlD
Cisapride—CYP2B6—brain—narcolepsy	0.000544	0.00526	CbGeAlD
Cisapride—HTR2A—brain—narcolepsy	0.000444	0.00429	CbGeAlD
Cisapride—CYP2D6—brain—narcolepsy	0.000404	0.00391	CbGeAlD
Cisapride—KCNH2—SIDS Susceptibility Pathways—HTR2A—narcolepsy	0.000323	0.00245	CbGpPWpGaD
Cisapride—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.000321	0.00243	CbGpPWpGaD
Cisapride—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.000321	0.00243	CbGpPWpGaD
Cisapride—HTR4—GPCR downstream signaling—HRH3—narcolepsy	0.000315	0.00238	CbGpPWpGaD
Cisapride—HTR2C—GPCR ligand binding—P2RY11—narcolepsy	0.000312	0.00236	CbGpPWpGaD
Cisapride—HTR2C—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.000311	0.00235	CbGpPWpGaD
Cisapride—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—narcolepsy	0.00031	0.00235	CbGpPWpGaD
Cisapride—HTR4—Signaling Pathways—HCRTR1—narcolepsy	0.000309	0.00234	CbGpPWpGaD
Cisapride—HTR4—Signaling Pathways—HCRTR2—narcolepsy	0.000309	0.00234	CbGpPWpGaD
Cisapride—DRD2—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.000308	0.00233	CbGpPWpGaD
Cisapride—HTR2A—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.000303	0.00229	CbGpPWpGaD
Cisapride—HTR4—Signaling Pathways—P2RY11—narcolepsy	0.000299	0.00226	CbGpPWpGaD
Cisapride—HTR2B—GPCR ligand binding—PENK—narcolepsy	0.000293	0.00222	CbGpPWpGaD
Cisapride—HTR2A—SIDS Susceptibility Pathways—TAC1—narcolepsy	0.000291	0.0022	CbGpPWpGaD
Cisapride—HTR2C—G alpha (q) signalling events—TAC1—narcolepsy	0.00029	0.00219	CbGpPWpGaD
Cisapride—HTR2C—G alpha (q) signalling events—NPS—narcolepsy	0.00029	0.00219	CbGpPWpGaD
Cisapride—HTR2B—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.000287	0.00217	CbGpPWpGaD
Cisapride—HTR4—Signaling by GPCR—HRH3—narcolepsy	0.000286	0.00217	CbGpPWpGaD
Cisapride—DRD2—GPCR ligand binding—HCRTR1—narcolepsy	0.000285	0.00216	CbGpPWpGaD
Cisapride—DRD2—GPCR ligand binding—HCRTR2—narcolepsy	0.000285	0.00216	CbGpPWpGaD
Cisapride—HTR2A—GPCR ligand binding—HCRTR1—narcolepsy	0.000281	0.00213	CbGpPWpGaD
Cisapride—HTR2A—GPCR ligand binding—HCRTR2—narcolepsy	0.000281	0.00213	CbGpPWpGaD
Cisapride—HTR4—GPCR ligand binding—HTR2A—narcolepsy	0.000278	0.0021	CbGpPWpGaD
Cisapride—DRD2—GPCR ligand binding—P2RY11—narcolepsy	0.000275	0.00209	CbGpPWpGaD
Cisapride—DRD2—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.000274	0.00208	CbGpPWpGaD
Cisapride—HTR2A—GPCR ligand binding—P2RY11—narcolepsy	0.000271	0.00205	CbGpPWpGaD
Cisapride—HTR2C—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00027	0.00205	CbGpPWpGaD
Cisapride—HTR2A—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00027	0.00204	CbGpPWpGaD
Cisapride—HTR2C—GPCR ligand binding—HCRT—narcolepsy	0.000265	0.00201	CbGpPWpGaD
Cisapride—HTR2C—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.000264	0.002	CbGpPWpGaD
Cisapride—HTR4—GPCR downstream signaling—TAC1—narcolepsy	0.000261	0.00198	CbGpPWpGaD
Cisapride—HTR4—GPCR downstream signaling—NPS—narcolepsy	0.000261	0.00198	CbGpPWpGaD
Cisapride—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.000259	0.00196	CbGpPWpGaD
Cisapride—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.000259	0.00196	CbGpPWpGaD
Cisapride—DRD2—G alpha (i) signalling events—HRH3—narcolepsy	0.000257	0.00195	CbGpPWpGaD
Cisapride—HTR4—Signaling Pathways—HCRT—narcolepsy	0.000254	0.00192	CbGpPWpGaD
Cisapride—HTR2A—G alpha (q) signalling events—NPS—narcolepsy	0.000252	0.00191	CbGpPWpGaD
Cisapride—HTR2A—G alpha (q) signalling events—TAC1—narcolepsy	0.000252	0.00191	CbGpPWpGaD
Cisapride—HTR2B—GPCR ligand binding—TRH—narcolepsy	0.000249	0.00189	CbGpPWpGaD
Cisapride—DRD2—Circadian rythm related genes—NPS—narcolepsy	0.000241	0.00183	CbGpPWpGaD
Cisapride—DRD2—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.000239	0.00181	CbGpPWpGaD
Cisapride—HTR2B—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.000238	0.0018	CbGpPWpGaD
Cisapride—HTR2B—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.000238	0.0018	CbGpPWpGaD
Cisapride—HTR4—Signaling by GPCR—NPS—narcolepsy	0.000237	0.00179	CbGpPWpGaD
Cisapride—HTR4—Signaling by GPCR—TAC1—narcolepsy	0.000237	0.00179	CbGpPWpGaD
Cisapride—HTR2C—GPCR ligand binding—PENK—narcolepsy	0.000237	0.00179	CbGpPWpGaD
Cisapride—HTR2A—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.000235	0.00178	CbGpPWpGaD
Cisapride—DRD2—GPCR ligand binding—HCRT—narcolepsy	0.000234	0.00177	CbGpPWpGaD
Cisapride—DRD2—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.000233	0.00177	CbGpPWpGaD
Cisapride—HTR2C—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.000232	0.00175	CbGpPWpGaD
Cisapride—HTR2A—GPCR ligand binding—HCRT—narcolepsy	0.00023	0.00175	CbGpPWpGaD
Cisapride—HTR2A—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.000229	0.00174	CbGpPWpGaD
Cisapride—HTR4—Signaling Pathways—PENK—narcolepsy	0.000226	0.00172	CbGpPWpGaD
Cisapride—HTR2B—GPCR downstream signaling—HCRTR2—narcolepsy	0.000226	0.00171	CbGpPWpGaD
Cisapride—HTR2B—GPCR downstream signaling—HCRTR1—narcolepsy	0.000226	0.00171	CbGpPWpGaD
Cisapride—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.000225	0.0017	CbGpPWpGaD
Cisapride—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.000225	0.0017	CbGpPWpGaD
Cisapride—HTR2B—GPCR downstream signaling—P2RY11—narcolepsy	0.000219	0.00166	CbGpPWpGaD
Cisapride—HTR2B—GPCR ligand binding—HRH3—narcolepsy	0.000219	0.00166	CbGpPWpGaD
Cisapride—HTR2B—G alpha (q) signalling events—HTR2A—narcolepsy	0.000216	0.00164	CbGpPWpGaD
Cisapride—DRD2—GPCR ligand binding—PENK—narcolepsy	0.000209	0.00158	CbGpPWpGaD
Cisapride—HTR2B—Signaling by GPCR—HCRTR1—narcolepsy	0.000206	0.00156	CbGpPWpGaD
Cisapride—HTR2B—Signaling by GPCR—HCRTR2—narcolepsy	0.000206	0.00156	CbGpPWpGaD
Cisapride—HTR2A—GPCR ligand binding—PENK—narcolepsy	0.000205	0.00156	CbGpPWpGaD
Cisapride—DRD2—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.000204	0.00155	CbGpPWpGaD
Cisapride—HTR2C—GPCR ligand binding—TRH—narcolepsy	0.000201	0.00152	CbGpPWpGaD
Cisapride—HTR2A—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.000201	0.00152	CbGpPWpGaD
Cisapride—HTR3A—SIDS Susceptibility Pathways—TNF—narcolepsy	0.0002	0.00152	CbGpPWpGaD
Cisapride—HTR2B—Signaling by GPCR—P2RY11—narcolepsy	0.000199	0.0015	CbGpPWpGaD
Cisapride—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.000193	0.00146	CbGpPWpGaD
Cisapride—HTR4—Signaling Pathways—TRH—narcolepsy	0.000193	0.00146	CbGpPWpGaD
Cisapride—HTR2C—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.000192	0.00145	CbGpPWpGaD
Cisapride—HTR2C—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.000192	0.00145	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.000187	0.00142	CbGpPWpGaD
Cisapride—HTR2B—GPCR downstream signaling—HCRT—narcolepsy	0.000186	0.00141	CbGpPWpGaD
Cisapride—HTR2C—GPCR downstream signaling—HCRTR2—narcolepsy	0.000183	0.00138	CbGpPWpGaD
Cisapride—HTR2C—GPCR downstream signaling—HCRTR1—narcolepsy	0.000183	0.00138	CbGpPWpGaD
Cisapride—HTR2B—GPCR ligand binding—TAC1—narcolepsy	0.000181	0.00137	CbGpPWpGaD
Cisapride—HTR2B—GPCR ligand binding—NPS—narcolepsy	0.000181	0.00137	CbGpPWpGaD
Cisapride—DRD2—GPCR ligand binding—TRH—narcolepsy	0.000177	0.00134	CbGpPWpGaD
Cisapride—HTR2C—GPCR downstream signaling—P2RY11—narcolepsy	0.000176	0.00134	CbGpPWpGaD
Cisapride—HTR2C—GPCR ligand binding—HRH3—narcolepsy	0.000176	0.00134	CbGpPWpGaD
Cisapride—HTR2A—GPCR ligand binding—TRH—narcolepsy	0.000175	0.00132	CbGpPWpGaD
Cisapride—HTR2C—G alpha (q) signalling events—HTR2A—narcolepsy	0.000174	0.00132	CbGpPWpGaD
Cisapride—DRD2—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.000169	0.00128	CbGpPWpGaD
Cisapride—DRD2—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.000169	0.00128	CbGpPWpGaD
Cisapride—HTR4—Signaling Pathways—HRH3—narcolepsy	0.000169	0.00128	CbGpPWpGaD
Cisapride—HTR2B—Signaling by GPCR—HCRT—narcolepsy	0.000169	0.00128	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.000167	0.00127	CbGpPWpGaD
Cisapride—HTR2B—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.000167	0.00127	CbGpPWpGaD
Cisapride—HTR2A—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.000167	0.00126	CbGpPWpGaD
Cisapride—HTR2A—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.000167	0.00126	CbGpPWpGaD
Cisapride—HTR2C—Signaling by GPCR—HCRTR2—narcolepsy	0.000166	0.00126	CbGpPWpGaD
Cisapride—HTR2C—Signaling by GPCR—HCRTR1—narcolepsy	0.000166	0.00126	CbGpPWpGaD
Cisapride—HTR2B—GPCR downstream signaling—PENK—narcolepsy	0.000166	0.00126	CbGpPWpGaD
Cisapride—DRD2—GPCR downstream signaling—HCRTR2—narcolepsy	0.000161	0.00122	CbGpPWpGaD
Cisapride—DRD2—GPCR downstream signaling—HCRTR1—narcolepsy	0.000161	0.00122	CbGpPWpGaD
Cisapride—HTR2C—Signaling by GPCR—P2RY11—narcolepsy	0.00016	0.00121	CbGpPWpGaD
Cisapride—HTR2A—GPCR downstream signaling—HCRTR2—narcolepsy	0.000159	0.0012	CbGpPWpGaD
Cisapride—HTR2A—GPCR downstream signaling—HCRTR1—narcolepsy	0.000159	0.0012	CbGpPWpGaD
Cisapride—HTR4—GPCR downstream signaling—HTR2A—narcolepsy	0.000157	0.00119	CbGpPWpGaD
Cisapride—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.000156	0.00118	CbGpPWpGaD
Cisapride—DRD2—GPCR downstream signaling—P2RY11—narcolepsy	0.000156	0.00118	CbGpPWpGaD
Cisapride—DRD2—GPCR ligand binding—HRH3—narcolepsy	0.000156	0.00118	CbGpPWpGaD
Cisapride—HTR2A—GPCR downstream signaling—P2RY11—narcolepsy	0.000153	0.00116	CbGpPWpGaD
Cisapride—HTR2A—GPCR ligand binding—HRH3—narcolepsy	0.000153	0.00116	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.000152	0.00116	CbGpPWpGaD
Cisapride—HTR2B—Signaling by GPCR—PENK—narcolepsy	0.00015	0.00114	CbGpPWpGaD
Cisapride—HTR2C—GPCR downstream signaling—HCRT—narcolepsy	0.00015	0.00114	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—HCRTR1—narcolepsy	0.000146	0.00111	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—HCRTR2—narcolepsy	0.000146	0.00111	CbGpPWpGaD
Cisapride—HTR2C—GPCR ligand binding—TAC1—narcolepsy	0.000146	0.00111	CbGpPWpGaD
Cisapride—HTR2C—GPCR ligand binding—NPS—narcolepsy	0.000146	0.00111	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—HCRTR1—narcolepsy	0.000144	0.00109	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—HCRTR2—narcolepsy	0.000144	0.00109	CbGpPWpGaD
Cisapride—HTR2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.000143	0.00108	CbGpPWpGaD
Cisapride—HTR4—Signaling by GPCR—HTR2A—narcolepsy	0.000142	0.00108	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—P2RY11—narcolepsy	0.000141	0.00107	CbGpPWpGaD
Cisapride—HTR2B—GPCR downstream signaling—TRH—narcolepsy	0.000141	0.00107	CbGpPWpGaD
Cisapride—HTR4—Signaling Pathways—TAC1—narcolepsy	0.00014	0.00106	CbGpPWpGaD
Cisapride—HTR4—Signaling Pathways—NPS—narcolepsy	0.00014	0.00106	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—P2RY11—narcolepsy	0.000139	0.00105	CbGpPWpGaD
Cisapride—KCNH2—SIDS Susceptibility Pathways—TNF—narcolepsy	0.000139	0.00105	CbGpPWpGaD
Cisapride—HTR2C—Signaling by GPCR—HCRT—narcolepsy	0.000136	0.00103	CbGpPWpGaD
Cisapride—HTR2C—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.000135	0.00102	CbGpPWpGaD
Cisapride—HTR2C—GPCR downstream signaling—PENK—narcolepsy	0.000134	0.00101	CbGpPWpGaD
Cisapride—CYP3A7—Metabolism—CHKB—narcolepsy	0.000133	0.00101	CbGpPWpGaD
Cisapride—DRD2—GPCR downstream signaling—HCRT—narcolepsy	0.000132	0.001	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.00013	0.000987	CbGpPWpGaD
Cisapride—HTR2A—GPCR downstream signaling—HCRT—narcolepsy	0.00013	0.000987	CbGpPWpGaD
Cisapride—DRD2—GPCR ligand binding—NPS—narcolepsy	0.000129	0.000977	CbGpPWpGaD
Cisapride—DRD2—GPCR ligand binding—TAC1—narcolepsy	0.000129	0.000977	CbGpPWpGaD
Cisapride—HTR2B—Signaling by GPCR—TRH—narcolepsy	0.000128	0.000969	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.000127	0.000965	CbGpPWpGaD
Cisapride—HTR2A—GPCR ligand binding—TAC1—narcolepsy	0.000127	0.000961	CbGpPWpGaD
Cisapride—HTR2A—GPCR ligand binding—NPS—narcolepsy	0.000127	0.000961	CbGpPWpGaD
Cisapride—HTR2B—GPCR downstream signaling—HRH3—narcolepsy	0.000124	0.000936	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—CHKB—narcolepsy	0.000122	0.000925	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—HCRTR2—narcolepsy	0.000121	0.00092	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—HCRTR1—narcolepsy	0.000121	0.00092	CbGpPWpGaD
Cisapride—HTR2C—Signaling by GPCR—PENK—narcolepsy	0.000121	0.00092	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—HCRT—narcolepsy	0.00012	0.00091	CbGpPWpGaD
Cisapride—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.000119	0.000901	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—HCRT—narcolepsy	0.000118	0.000896	CbGpPWpGaD
Cisapride—DRD2—GPCR downstream signaling—PENK—narcolepsy	0.000118	0.000894	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—P2RY11—narcolepsy	0.000117	0.000888	CbGpPWpGaD
Cisapride—HTR2A—GPCR downstream signaling—PENK—narcolepsy	0.000116	0.000879	CbGpPWpGaD
Cisapride—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.000115	0.000875	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.000114	0.000861	CbGpPWpGaD
Cisapride—HTR2C—GPCR downstream signaling—TRH—narcolepsy	0.000114	0.000861	CbGpPWpGaD
Cisapride—HTR2B—Signaling by GPCR—HRH3—narcolepsy	0.000112	0.00085	CbGpPWpGaD
Cisapride—HTR2B—GPCR ligand binding—HTR2A—narcolepsy	0.000109	0.000825	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—PENK—narcolepsy	0.000107	0.000812	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—PENK—narcolepsy	0.000105	0.000798	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.000104	0.000785	CbGpPWpGaD
Cisapride—HTR2C—Signaling by GPCR—TRH—narcolepsy	0.000103	0.000782	CbGpPWpGaD
Cisapride—HTR2B—GPCR downstream signaling—TAC1—narcolepsy	0.000102	0.000775	CbGpPWpGaD
Cisapride—HTR2B—GPCR downstream signaling—NPS—narcolepsy	0.000102	0.000775	CbGpPWpGaD
Cisapride—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.000102	0.000772	CbGpPWpGaD
Cisapride—CYP1A2—Aryl Hydrocarbon Receptor—TNF—narcolepsy	0.0001	0.000761	CbGpPWpGaD
Cisapride—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—narcolepsy	0.0001	0.000761	CbGpPWpGaD
Cisapride—DRD2—GPCR downstream signaling—TRH—narcolepsy	0.0001	0.00076	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—HCRT—narcolepsy	9.97e-05	0.000755	CbGpPWpGaD
Cisapride—HTR2C—GPCR downstream signaling—HRH3—narcolepsy	9.97e-05	0.000755	CbGpPWpGaD
Cisapride—HTR2A—GPCR downstream signaling—TRH—narcolepsy	9.87e-05	0.000748	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—CHKB—narcolepsy	9.86e-05	0.000747	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—HCRTR1—narcolepsy	9.8e-05	0.000742	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—HCRTR2—narcolepsy	9.8e-05	0.000742	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—CHKB—narcolepsy	9.63e-05	0.00073	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—P2RY11—narcolepsy	9.46e-05	0.000717	CbGpPWpGaD
Cisapride—HTR2B—Signaling by GPCR—NPS—narcolepsy	9.29e-05	0.000704	CbGpPWpGaD
Cisapride—HTR2B—Signaling by GPCR—TAC1—narcolepsy	9.29e-05	0.000704	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—TRH—narcolepsy	9.11e-05	0.00069	CbGpPWpGaD
Cisapride—CYP3A7—Metabolism—CPT1B—narcolepsy	9.06e-05	0.000686	CbGpPWpGaD
Cisapride—HTR2C—Signaling by GPCR—HRH3—narcolepsy	9.05e-05	0.000686	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—TRH—narcolepsy	8.96e-05	0.000679	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—PENK—narcolepsy	8.89e-05	0.000673	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	8.86e-05	0.000671	CbGpPWpGaD
Cisapride—DRD2—GPCR downstream signaling—HRH3—narcolepsy	8.8e-05	0.000666	CbGpPWpGaD
Cisapride—HTR2C—GPCR ligand binding—HTR2A—narcolepsy	8.79e-05	0.000666	CbGpPWpGaD
Cisapride—HTR2A—GPCR downstream signaling—HRH3—narcolepsy	8.65e-05	0.000656	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—HCRTR1—narcolepsy	8.65e-05	0.000655	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—HCRTR2—narcolepsy	8.65e-05	0.000655	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—HCRTR1—narcolepsy	8.51e-05	0.000644	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—HCRTR2—narcolepsy	8.51e-05	0.000644	CbGpPWpGaD
Cisapride—HTR4—Signaling Pathways—HTR2A—narcolepsy	8.42e-05	0.000638	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—P2RY11—narcolepsy	8.35e-05	0.000633	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—CHKB—narcolepsy	8.34e-05	0.000632	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—CPT1B—narcolepsy	8.3e-05	0.000629	CbGpPWpGaD
Cisapride—HTR2C—GPCR downstream signaling—TAC1—narcolepsy	8.26e-05	0.000626	CbGpPWpGaD
Cisapride—HTR2C—GPCR downstream signaling—NPS—narcolepsy	8.26e-05	0.000626	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—P2RY11—narcolepsy	8.22e-05	0.000622	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—HCRT—narcolepsy	8.04e-05	0.000609	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—HRH3—narcolepsy	7.99e-05	0.000605	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—HRH3—narcolepsy	7.86e-05	0.000595	CbGpPWpGaD
Cisapride—DRD2—GPCR ligand binding—HTR2A—narcolepsy	7.76e-05	0.000588	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—TRH—narcolepsy	7.56e-05	0.000572	CbGpPWpGaD
Cisapride—HTR2A—SIDS Susceptibility Pathways—TNF—narcolepsy	7.52e-05	0.00057	CbGpPWpGaD
Cisapride—HTR2C—Signaling by GPCR—NPS—narcolepsy	7.5e-05	0.000568	CbGpPWpGaD
Cisapride—HTR2C—Signaling by GPCR—TAC1—narcolepsy	7.5e-05	0.000568	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—CHKB—narcolepsy	7.45e-05	0.000564	CbGpPWpGaD
Cisapride—DRD2—GPCR downstream signaling—TAC1—narcolepsy	7.29e-05	0.000552	CbGpPWpGaD
Cisapride—DRD2—GPCR downstream signaling—NPS—narcolepsy	7.29e-05	0.000552	CbGpPWpGaD
Cisapride—HTR2A—GPCR downstream signaling—NPS—narcolepsy	7.17e-05	0.000543	CbGpPWpGaD
Cisapride—HTR2A—GPCR downstream signaling—TAC1—narcolepsy	7.17e-05	0.000543	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—PENK—narcolepsy	7.17e-05	0.000543	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—HCRT—narcolepsy	7.1e-05	0.000538	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—HCRT—narcolepsy	6.99e-05	0.000529	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—CHKB—narcolepsy	6.85e-05	0.000519	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—CHKB—narcolepsy	6.79e-05	0.000514	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—CPT1B—narcolepsy	6.7e-05	0.000508	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—HRH3—narcolepsy	6.63e-05	0.000502	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—NPS—narcolepsy	6.62e-05	0.000501	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—TAC1—narcolepsy	6.62e-05	0.000501	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—CPT1B—narcolepsy	6.55e-05	0.000496	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—TAC1—narcolepsy	6.51e-05	0.000493	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—NPS—narcolepsy	6.51e-05	0.000493	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—PENK—narcolepsy	6.33e-05	0.000479	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—PENK—narcolepsy	6.23e-05	0.000472	CbGpPWpGaD
Cisapride—HTR2B—GPCR downstream signaling—HTR2A—narcolepsy	6.16e-05	0.000466	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—TRH—narcolepsy	6.1e-05	0.000462	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—CHKB—narcolepsy	5.8e-05	0.00044	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—CPT1B—narcolepsy	5.67e-05	0.00043	CbGpPWpGaD
Cisapride—HTR2B—Signaling by GPCR—HTR2A—narcolepsy	5.59e-05	0.000424	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—TAC1—narcolepsy	5.49e-05	0.000416	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—NPS—narcolepsy	5.49e-05	0.000416	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—TRH—narcolepsy	5.38e-05	0.000408	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—HRH3—narcolepsy	5.35e-05	0.000405	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—TRH—narcolepsy	5.29e-05	0.000401	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—CPT1B—narcolepsy	5.06e-05	0.000384	CbGpPWpGaD
Cisapride—HTR2C—GPCR downstream signaling—HTR2A—narcolepsy	4.97e-05	0.000376	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—HRH3—narcolepsy	4.72e-05	0.000357	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—CPT1B—narcolepsy	4.66e-05	0.000353	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—HRH3—narcolepsy	4.64e-05	0.000352	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—CPT1B—narcolepsy	4.62e-05	0.00035	CbGpPWpGaD
Cisapride—HTR2C—Signaling by GPCR—HTR2A—narcolepsy	4.51e-05	0.000342	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—CHKB—narcolepsy	4.48e-05	0.000339	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—TAC1—narcolepsy	4.43e-05	0.000336	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—NPS—narcolepsy	4.43e-05	0.000336	CbGpPWpGaD
Cisapride—DRD2—GPCR downstream signaling—HTR2A—narcolepsy	4.38e-05	0.000332	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—HTR2A—narcolepsy	3.98e-05	0.000302	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—CPT1B—narcolepsy	3.94e-05	0.000299	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—TAC1—narcolepsy	3.91e-05	0.000296	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—NPS—narcolepsy	3.91e-05	0.000296	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—TAC1—narcolepsy	3.85e-05	0.000291	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—NPS—narcolepsy	3.85e-05	0.000291	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—HTR2A—narcolepsy	3.3e-05	0.00025	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—CPT1B—narcolepsy	3.04e-05	0.000231	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—HTR2A—narcolepsy	2.66e-05	0.000202	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—HTR2A—narcolepsy	2.35e-05	0.000178	CbGpPWpGaD
